Acquisitions And Other Arrangements (Tables)

6 Months Ended

Jun. 30, 2015

OnCure

Acquisitions [Line Items]

Schedule Of the Allocation Of The Purchase Price

Acquisition Consideration
Cash	$	42,250
11.75% senior secured notes due January 2017		75,000
Assumed capital lease obligations & other notes		2,090
Fair value of contingent earn-out, represented by 11.75% senior secured notes due January 2017 issued into escrow		7,550
Total acquisition consideration	$	126,890

Summary Of Allocation Of The Aggregate Purchase Price, Including Assumed Liabilities

Acquisition Consideration Allocation
Cash and cash equivalents	$	307
Accounts receivable		10,087
Inventories		200
Deferred income taxes—asset		4,875
Other currents assets		1,742
Accounts payable		(4,856)
Accrued expenses		(3,540)
Other current liabilities		—
Equity investments in joint ventures		1,625
Property and equipment		22,397
Intangible assets—management services agreements		57,739
Other noncurrent assets		265
Other long—term liabilities		(5,828)
Deferred income taxes—liability		(32,052)
Noncontrolling interest—nonredeemable		(1,299)
Goodwill		75,228
Acquisition consideration	$	126,890

Schedule Of Preliminary Intangible Assets Included In Net Identifiable Assets

Management service agreements $ 57,739 

Schedule Of Estimated Future Amortization Expense

2014	$	5,563
2015	$	5,563
2016	$	5,464
2017	$	5,464
2018	$	5,195
Thereafter	$	29,564

Radiation Oncology Practice And Urology Groups [Member]

Acquisitions [Line Items]

Schedule Of Estimated Future Amortization Expense

2014	$	2,365
2015	$	2,580
2016	$	2,580
2017	$	1,938
2018	$	1,880
Thereafter	$	157

South Florida Radiation Oncology

Acquisitions [Line Items]

Schedule Of the Allocation Of The Purchase Price

Acquisition Consideration
Cash	$	432
Term B Loan (net of original issue discount)		57,300
Seller financing note		2,000
Working capital settlement		(5,333)
Fair value of contingent earn-out		11,052
Total acquisition consideration	$	65,451

Summary Of Allocation Of The Aggregate Purchase Price, Including Assumed Liabilities

Acquisition Consideration Allocation
Accounts receivable	$	12,676
Other currents assets		1,364
Current liabilities		(21,287)
Property and equipment		20,750
Intangible assets—(non-compete and tradename)		11,500
Other noncurrent assets		910
Long-term debt		(42,021)
Other long—term liabilities		(1,969)
Noncontrolling interest—redeemable		(39,925)
Goodwill		123,453
Acquisition consideration	$	65,451

Schedule Of Preliminary Intangible Assets Included In Net Identifiable Assets

Trade name (3 year life)	$	2,100
Non-compete agreement (5 year life)		9,400
	$	11,500

Schedule Of Unaudited Pro Forma Financial Information

(in thousands):	Six Months Ended June 30, 2014
Pro forma total revenues	$	510,314
Pro forma net loss attributable to 21st Century Oncology Holdings, Inc. shareholder	$	(238,431)